No, atrial fibrillation does not cause diabetes
Atrial fibrillation (AF) does not directly cause diabetes mellitus. The relationship between these two conditions flows in the opposite direction: diabetes is a risk factor for developing AF, not the other way around.
The Directional Relationship
The evidence consistently demonstrates that diabetes increases the risk of AF development, not vice versa:
Diabetes as an AF risk factor: Multiple guidelines confirm that diabetes is associated with increased AF incidence 1, 2, 3. The Manitoba Follow-up Study showed diabetes was associated with AF with a relative risk of 1.82 in univariate analysis 1, 2.
The association is not independent: Critically, when adjusted for other cardiovascular conditions (ischemic heart disease, hypertension, heart failure), the independent association between diabetes and AF becomes insignificant 1, 2. This suggests the increased AF risk in diabetic patients depends primarily on these coexisting cardiovascular conditions rather than diabetes directly causing AF.
Shared risk factors, not causation: Diabetes and AF share common antecedents including hypertension, atherosclerosis, and obesity 2. These shared metabolic and cardiovascular risk factors explain their frequent coexistence without implying causation in either direction.
What Actually Happens
The pathophysiological mechanisms work as follows:
- Diabetes contributes to atrial structural, electrical, and autonomic remodeling that creates a substrate favorable for AF development 4, 5
- Hyperglycemia, insulin resistance, oxidative stress, inflammation, and atrial fibrosis in diabetes facilitate AF initiation and persistence 5
- Once both conditions coexist, they create a high-risk cardiometabolic phenotype with substantially increased mortality, cardiovascular death, stroke, and heart failure risk 2, 3
The Exception: Acute Hyperglycemia
There is one documented case report where symptomatic AF caused severe hyperglycemia requiring a 10-fold increase in insulin requirements (from 21 to 215 units/day), which resolved after cardioversion 6. However, this represents acute metabolic stress from symptomatic AF, not AF causing diabetes as a chronic disease state.
Clinical Implications
When you encounter patients with both conditions:
- Screen diabetic patients for AF: Screening is recommended for patients with diabetes aged >65 years by pulse palpation or wearable devices, confirmed by ECG 3
- Recognize diabetes as a modifiable AF risk factor: Effective glycemic control and comprehensive cardiometabolic management (treating obesity, hypertension, heart failure) should be prioritized to reduce AF burden and recurrence 7
- Anticoagulation is mandatory: All patients with diabetes and AF require anticoagulation for stroke prevention, as diabetes increases thromboembolic risk in AF 2, 3
The most recent 2024 ESC Guidelines emphasize that metformin or SGLT2 inhibitors should be considered for individuals needing pharmacological diabetes management specifically to prevent AF 7, further confirming the directional relationship where diabetes management prevents AF, not the reverse.